Using tobacco to thwart infectious disease?
Friday, March 28, 2014 - 14:00
in Health & Medicine
A new generation of potentially safer and more cost-effective therapeutics against West Nile virus, and other pathogens has been developed by an international research group. The therapeutics, known as monoclonal antibodies and their derivatives, were shown to neutralize and protect mice against a lethal dose challenge of West Nile virus -- even as late as four days after the initial infection.